Post-COVID Interstitial Lung Disease: How do We Deal with This New Entity?
Aycan YükselDilek KaradoğanNur HürsoyTahsin Gökhan TelatarNeslihan KöseFeride Marımİlknur KayaAslıhan Banu ErMerve ErcelikDemet Polat YuluğMerve Yumrukuz SenelCeren IlgarÖkkeş GültekinSelin ÇakmakcıBilge Yılmaz KaraNeslihan Ozcelikİnci SelimoğluKübra Uyar ErAbdurrahman KotanHasan Veysel KesinMetin AkgünPublished in: Balkan medical journal (2024)
The co-existence of respiratory symptoms, radiological parenchymal lesions, and pulmonary functional abnormalities which suggest a restrictive ventilatory defect should be defined as post-COVID-19 ILD. However, the term "fibrosis" should be used carefully. Active smoking, severe COVID-19, and elevated lactate dehydrogenase level are the main risk factors of this condition. These post-COVID functional and radiological changes could disappear over time in 20% of the patients.
Keyphrases
- coronavirus disease
- sars cov
- interstitial lung disease
- systemic sclerosis
- risk factors
- end stage renal disease
- rheumatoid arthritis
- pulmonary hypertension
- respiratory syndrome coronavirus
- ejection fraction
- chronic kidney disease
- idiopathic pulmonary fibrosis
- newly diagnosed
- prognostic factors
- early onset
- smoking cessation
- peritoneal dialysis
- physical activity